Sawai Group Holdings Co., Ltd. (TYO:4887)

Market Cap	213.70B
Revenue (ttm)	189.02B
Net Income (ttm)	22.94B
Shares Out	115.45M
EPS (ttm)	184.44
PE Ratio	17.52
Forward PE	12.16
Dividend	55.00 (3.00%)
Ex-Dividend Date	Mar 28, 2025

Volume	437,300
Average Volume	468,405
Open	1,807.00
Previous Close	1,807.00
Day's Range	1,804.00 - 1,828.50
52-Week Range	1,650.00 - 2,308.66
Beta	-0.03
RSI	49.11
Earnings Date	Aug 12, 2025

About Sawai Group Holdings

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 3,482
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4887

Financial Performance

In 2024, Sawai Group Holdings's revenue was 189.02 billion, an increase of 6.88% compared to the previous year's 176.86 billion. Earnings were 22.94 billion, an increase of 67.49%.